Brief: CLS's Acting CEO Dan J. Mogren To Go On Planned Sick Leave
Feb 10 (Reuters) - Clinical Laserthermia Systems AB
CLSRb.ST :
* CLS'S ACTING CEO DAN J. MOGREN WILL GO ON A PLANNED SICK
LEAVE
* ACTING CEO DAN J. MOGREN WILL GO ON A PLANNED SICK LEAVE
ON FEB
10TH UNTIL MARCH 31ST
* LARS-ERIK ERIKSSON, COMPANY CFO AND PREVIOUS CEO, DEPUTY
CEO
DURING THIS PERIOD
Source text for Eikon: ID:nWkr5P9sGD
Further company coverage: CLSRb.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Clinical Laserthermia Systems AB
See all newsBrief: CLS Enters Research Agreement With U.S. National Cancer Institute
Sweden's CLS Q1 sales fall 72% after partner talks
Brief: Clinical Laserthermia Systems Q1 EBIT Sek 1.7 Mln
Brief: CLS Receives Order Worth SEK 23 Mln For Prism Business
Brief: CLS Expects To Achieve Positive Cash Flow From Q4 2026 To Q1 2028